Literature DB >> 29351494

Factors Associated with Sarcopenia in Patients with Colorectal Cancer.

Bianca Umbelino de Souza1, Nilian Carla Silva Souza1,2, Renata Brum Martucci1,2, Viviane Dias Rodrigues1, Nivaldo Barroso de Pinho1, Maria Cristina Gonzalez3, Carla Maria Avesani2.   

Abstract

Introduction; Sarcopenia are frequently observed in cancer patients and was associated with poor prognosis. Objectives; to determine the association of nutritional status, body composition, and clinic parameters with sarcopenia in patients with colorectal cancer (CRC). Methods; We conducted a cross-sectional study of 197 patients with CRC. The sarcopenia elements, including lumbar skeletal muscle index (SMI), handgrip strength, and gait speed were measured. The SMI was assessed by computed tomography at third lumbar vertebra. Phase angle (PA), serum albumin (SAlb), muscle attenuation (MA), and the scored patient-generated subjective global assessment (PG-SGA) were also evaluated. Univariate and multivariate analysis of factors associated with sarcopenia were performed. Results; Sarcopenia was present in 29 of 195 patients (15%) and was significantly correlated with advance age, lower body mass index (BMI), SAlb, PA, MA, higher PG-SGA score, and malnutrition (PG-SGA B). In univariate analysis, age, BMI, SAlb, PA, MA, PG-SGA score, and malnutrition (PG-SGA B) were associated with sarcopenia. Multivariable analysis revealed that BMI, SAlb, PA, MA, and PG-SGA score were independent predictors of sarcopenia. Conclusion; BMI, SAlb, PA, MA, and PG-SGA score were independent predictors of sarcopenia in patients with CRC.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29351494     DOI: 10.1080/01635581.2018.1412480

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  5 in total

1.  Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis.

Authors:  Guangwei Sun; Yalun Li; Yangjie Peng; Dapeng Lu; Fuqiang Zhang; Xueyang Cui; Qingyue Zhang; Zhuang Li
Journal:  Int J Colorectal Dis       Date:  2018-07-10       Impact factor: 2.571

2.  Factors associated with muscle function in patients with hematologic malignancies undergoing chemotherapy.

Authors:  Takuya Fukushima; Jiro Nakano; Shun Ishii; Ayumi Natsuzako; Shuntaro Sato; Junya Sakamoto; Yasushi Miyazaki; Minoru Okita
Journal:  Support Care Cancer       Date:  2019-07-03       Impact factor: 3.603

3.  Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapy.

Authors:  Emanuele Cereda; Annalisa Turri; Catherine Klersy; Silvia Cappello; Alessandra Ferrari; Andrea Riccardo Filippi; Silvia Brugnatelli; Marilisa Caraccia; Silvia Chiellino; Valeria Borioli; Teresa Monaco; Giulia Maria Stella; Luca Arcaini; Marco Benazzo; Giuseppina Grugnetti; Paolo Pedrazzoli; Riccardo Caccialanza
Journal:  Cancer Med       Date:  2019-09-30       Impact factor: 4.452

4.  Prognostic value of cardio-hepatic-skeletal muscle syndrome in patients with heart failure.

Authors:  Takumi Noda; Kentaro Kamiya; Nobuaki Hamazaki; Kohei Nozaki; Takafumi Ichikawa; Takeshi Nakamura; Masashi Yamashita; Shota Uchida; Emi Maekawa; Jennifer L Reed; Minako Yamaoka-Tojo; Atsuhiko Matsunaga; Junya Ako
Journal:  Sci Rep       Date:  2021-02-12       Impact factor: 4.379

5.  CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis.

Authors:  Huaiying Su; Junxian Ruan; Tianfeng Chen; Enyi Lin; Lijing Shi
Journal:  Cancer Imaging       Date:  2019-12-03       Impact factor: 3.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.